(UroToday.com) In the second Prostate Cancer session at this year’s Society of Urologic Oncology (SUO) virtual annual meeting, Dr. Kara Maxwell provided an overview of biomarkers for patients with advanced prostate cancer. While many urologists are familiar with and may use, tissue-based biomarkers in early disease, there is an increasing number of actionable biomarkers in advanced disease.